AIDS and Behavior

, 15:1635 | Cite as

Computer-Based Intervention in HIV Clinical Care Setting Improves Antiretroviral Adherence: The LifeWindows Project

  • Jeffrey D. FisherEmail author
  • K. Rivet Amico
  • William A. Fisher
  • Deborah H. Cornman
  • Paul A. Shuper
  • Cynthia Trayling
  • Caroline Redding
  • William Barta
  • Anthony F. Lemieux
  • Frederick L. Altice
  • Kevin Dieckhaus
  • Gerald Friedland
  • for the LifeWindows Team
Original Paper


We evaluated the efficacy of LifeWindows, a theory-based, computer-administered antiretroviral (ARV) therapy adherence support intervention, delivered to HIV + patients at routine clinical care visits. 594 HIV + adults receiving HIV care at five clinics were randomized to intervention or control arms. Intervention vs. control impact in the intent-to-treat sample (including participants whose ARVs had been entirely discontinued, who infrequently attended care, or infrequently used LifeWindows) did not reach significance. Intervention impact in the On Protocol sample (328 intervention and control arm participants whose ARVs were not discontinued, who attended care and were exposed to LifeWindows regularly) was significant. On Protocol intervention vs. control participants achieved significantly higher levels of perfect 3-day ACTG-assessed adherence over time, with sensitivity analyses maintaining this effect down to 70% adherence. This study supports the utility of LifeWindows and illustrates that patients on ARVs who persist in care at clinical care sites can benefit from adherence promotion software.


ARV Adherence Intervention IMB-model ART 


Evaluamos la eficacia de LifeWindows, una intervención de apoyo para la adherencia a la terapia antirretroviral (TAR) basada en teoría y con administración informatizada para pacientes con VIH + en sus visitas clínicas rutinarias. 594 adultos de cinco clínicas con VIH + y bajo tratamiento fueron aleatoriamente asignados a un grupo de intervención o de control. No se alcanzó significación estadística al comparar ambos grupos bajo la estrategia de ‘intención de tratar’ (incluyendo los participantes cuyos TAR se habían interrumpido por completo, habían asistido a la clínica en pocas ocasiones, o usaron LifeWindows con poca frecuencia). Sin embargo, la intervención obtuvo un impacto significativo cuando se evaluó con la muestra bajo Protocolo (un total de 328 participantes cuyos TAR no fueron interrumpidos, asistieron a sus visitas clínicas y se expusieron a LifeWindows regularmente). Los participantes bajo Protocolo de intervención obtuvieron niveles más altos de adherencia que el grupo control en tres días de Estudios de Grupos Clinicos con SIDA (EGCS) con repetidas evaluaciones y manteniendo como mínimo un 70% de la adherencia. Este estudio apoya la utilidad de LifeWindows e indica que los pacientes con TAR que asisten a las visitas clínicas, pueden beneficiarse de este software de promoción de la adherencia.


AR Adherencia Intervención IMB-modelo TAR 



This study was funded by a National Institute of Mental Health grant (5 R01 MH066684), Jeffrey D. Fisher, Principal Investigator.


  1. 1.
    Chen LF, Hoy J, Lewin SR. Ten years of highly active antiretroviral therapy for HIV infection. Med J Aust. 2007;186:146–51.PubMedGoogle Scholar
  2. 2.
    Waters L, Nelson M. Why do patients fail HIV therapy? Int J Clin Pract. 2007;61:983–90.PubMedCrossRefGoogle Scholar
  3. 3.
    Simoni J, Amico KR, Pearson C, Malow R. Overview of adherence to antiretroviral therapies. In: Pope C, White RT, Malow R, editors. Global frontiers in prevention/intervention. New York: Taylor & Francis Publications, Inc.; 2008. p. 191–200.Google Scholar
  4. 4.
    Curioso WH, Kurth AE, Blas MM, Klausner JD. Information and communication technologies for prevention and control of HIV infection and other STIs. In: Holmes KK, et al., editors. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill; 2007. p. 2057–74.Google Scholar
  5. 5.
    Nieuwkerk PT, Sprangers MA, Burger DM, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med. 2001;16:1962–8.CrossRefGoogle Scholar
  6. 6.
    Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197(Suppl 3):S272–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Bangsberg DR, Acosta EP, Gupta R, et al. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20:223–31.PubMedCrossRefGoogle Scholar
  8. 8.
    Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med. 2002;17:812–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr. 2002;29(Suppl 1):S2–10.PubMedGoogle Scholar
  10. 10.
    Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMedGoogle Scholar
  11. 11.
    Conway B. The role of adherence to antiretroviral therapy in the management of HIV infection. J Acquir Immune Defic Syndr. 2007;45(Suppl 1):S14–8.PubMedGoogle Scholar
  12. 12.
    Lazo M, Gange SJ, Wilson TE, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis. 2007;45:1377–85.PubMedCrossRefGoogle Scholar
  13. 13.
    Fumaz CR, Munoz-Moreno J, Molto J, et al. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs. AIDS Care. 2008;20:796–805.PubMedCrossRefGoogle Scholar
  14. 14.
    Kleeberger CA, Buechner J, Palella F, et al. Changes in adherence to highly active antiretroviral therapy medications in the multicenter AIDS cohort study. AIDS. 2004;18:683–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Munro S, Lewin S, Swart T, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health. 2007;7:104.PubMedCrossRefGoogle Scholar
  16. 16.
    Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25:462–73.PubMedCrossRefGoogle Scholar
  17. 17.
    Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care. 2005;17:661–73.PubMedCrossRefGoogle Scholar
  18. 18.
    Amico KR, Barta W, Konkle-Parker DJ, et al. The information-motivation-behavioral skills model of ART adherence in a deep south HIV + clinic sample. AIDS Behav. 2009;13:66–75.PubMedCrossRefGoogle Scholar
  19. 19.
    Starace F, Massa A, Amico KR, Fisher JD. Adherence to antiretroviral therapy: an empirical test of the information-motivation-behavioral skills model. Health Psychol. 2006;25:153–62.PubMedCrossRefGoogle Scholar
  20. 20.
    Kalichman SC, Rompa D, DiFonzo K, et al. HIV treatment adherence in women living with HIV/AIDS: research based on the information-motivation-behavioral skills model of health behavior. J Assoc Nurses AIDS Care. 2001;12:58–67.PubMedCrossRefGoogle Scholar
  21. 21.
    Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22:223–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Kalichman SC, Cherry J, Cain D. Nurse-delivered antiretroviral treatment adherence intervention for people with low literacy skills and living with HIV/AIDS. J Assoc Nurses AIDS Care. 2005;16:3–15.PubMedGoogle Scholar
  23. 23.
    Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S41–7.PubMedGoogle Scholar
  24. 24.
    Wagner GJ, Kanouse DE, Golinelli D, et al. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006;20:1295–302.PubMedCrossRefGoogle Scholar
  25. 25.
    Pearson CR, Micek M, Simoni JM, Matediana E, Martin DP, Gloyd S. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S134–41.PubMedGoogle Scholar
  26. 26.
    Pearson CR, Micek MA, Simoni JM, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr. 2007;46:238–44.PubMedCrossRefGoogle Scholar
  27. 27.
    Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46:443–50.PubMedCrossRefGoogle Scholar
  28. 28.
    Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41:285–97.PubMedCrossRefGoogle Scholar
  29. 29.
    Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.PubMedGoogle Scholar
  30. 30.
    Amico KR, Harman JJ, O’Grady M, Johnson B. Research synthesis of ART adherence interventions: a synthesis of published adherence intervention outcomes research from 1996 to September 2007. In: Presented at the 4th Annual HIV Treatment Adherence Conference of the International Association of Providers in AIDS Care, Miami, FL. April 2009.Google Scholar
  31. 31.
    Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10:515–21.PubMedCrossRefGoogle Scholar
  32. 32.
    Harman JJ, Amico KR, Johnson BT. Standard of care: promoting antiretroviral adherence in clinical care. AIDS Care. 2005;17:237–51.PubMedCrossRefGoogle Scholar
  33. 33.
    Portnoy DB, Scott-Sheldon LA, Johnson BT, Carey MP. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47:3–16.PubMedCrossRefGoogle Scholar
  34. 34.
    Walters ST, Wright JA, Shegog R. A review of computer and Internet-based interventions for smoking behavior. Addict Behav. 2006;31:264–77.PubMedCrossRefGoogle Scholar
  35. 35.
    Williams GC, Lynch M, Glasgow RE. Computer-assisted intervention improves patient-centered diabetes care by increasing autonomy support. Health Psychol. 2007;26:728–34.PubMedCrossRefGoogle Scholar
  36. 36.
    Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23:107–15.PubMedCrossRefGoogle Scholar
  37. 37.
    Curioso WH, Kurth AE. Access, use and perceptions regarding Internet, cell phones and PDAs as a means for health promotion for people living with HIV in Peru. BMC Med Inform Decis Mak. 2007;7:24–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Brock TP, Smith SR. Using digital videos displayed on personal digital assistants (PDAs) to enhance patient education in clinical settings. Int J Med Inf. 2007;76:829–35.CrossRefGoogle Scholar
  39. 39.
    Côté J, Godin G, Garcia PR, Gagnon M, Rouleau G. Program development for enhancing adherence to antiretroviral therapy among persons living with HIV. AIDS Patient Care STDS. 2008;22:965–75.PubMedCrossRefGoogle Scholar
  40. 40.
    The LifeWindows Project Team. The LifeWindows Information-Motivation Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ). Center for Health, Intervention, and Prevention, University of Connecticut, 2006.Google Scholar
  41. 41.
    Ware J, Kosinski M, Dewey J, Gandek B. A manual for users of the SF-8 health survey. Lincoln: QualityMetric Incorporated; 2001.Google Scholar
  42. 42.
    Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). AIDS Care. 2000;12(3):255–66.PubMedCrossRefGoogle Scholar
  43. 43.
    Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16:269–77.PubMedCrossRefGoogle Scholar
  44. 44.
    Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Deficiency Syndr. 2004;36:1100–2.CrossRefGoogle Scholar
  45. 45.
    Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.PubMedCrossRefGoogle Scholar
  46. 46.
    Raudenbush S, Bryk A, Cheong YF, Congdon R, du Toit M. HLM 6: hierarchical linear and nonlinear modeling. Lincolnwood: Scientific Software International; 2004.Google Scholar
  47. 47.
    Department of Health and Human Services (DHHS) Office of AIDS Research Advisory Council (OARAC). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services. Accessed 10 Jan 2008.
  48. 48.
    Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16(5):156–61.PubMedGoogle Scholar
  49. 49.
    Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010;24(17):2665–78.PubMedCrossRefGoogle Scholar
  50. 50.
    Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5:193–203.PubMedCrossRefGoogle Scholar
  51. 51.
    Amico KR, Shuper PA, Cornman DH, et al. Patterns of use of a computer-delivered adherence intervention: preliminary results from the LifeWindows Project. Paper presented at the NIMH/IAPAC International Conference on HIV Treatment Adherence, Jersey City, NJ. March 2007.Google Scholar
  52. 52.
    Shuper PA, Fisher JD, Cornman DH, et al. Changing ART adherence using theory-based, computer-delivered interventions. Poster presented at the NIMH/IAPAC International Conference on HIV Treatment Adherence, Jersey City, NJ. March 2006.Google Scholar
  53. 53.
    Rosenblum M, Deeks SG, van der Laan M, Bangsberg DR. The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS One. 2009;4(9):e7196.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Jeffrey D. Fisher
    • 1
    • 2
    Email author
  • K. Rivet Amico
    • 2
  • William A. Fisher
    • 3
  • Deborah H. Cornman
    • 2
  • Paul A. Shuper
    • 4
    • 5
  • Cynthia Trayling
    • 4
  • Caroline Redding
    • 2
  • William Barta
    • 2
  • Anthony F. Lemieux
    • 6
  • Frederick L. Altice
    • 7
  • Kevin Dieckhaus
    • 8
  • Gerald Friedland
    • 7
  • for the LifeWindows Team
  1. 1.Department of PsychologyUniversity of ConnecticutStorrsUSA
  2. 2.Center for Health, Intervention, and Prevention (CHIP)University of ConnecticutStorrsUSA
  3. 3.Departments of Psychology and Obstetrics and GynecologyUniversity of Western OntarioLondonCanada
  4. 4.Centre for Addiction and Mental HealthTorontoCanada
  5. 5.Department of PsychologyUniversity of TorontoTorontoCanada
  6. 6.School of Natural and Social Sciences, Purchase CollegeState University of New YorkPurchaseUSA
  7. 7.AIDS Program, Department of Internal MedicineYale University School of MedicineNew HavenUSA
  8. 8.University of Connecticut Health CenterFarmingtonUSA

Personalised recommendations